{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:46:28Z","timestamp":1761176788510,"version":"build-2065373602"},"reference-count":39,"publisher":"Wiley","issue":"17","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2025,9]]},"abstract":"ABSTRACT<\/jats:title>\n \n Objective<\/jats:title>\n To evaluate the clinical and prognostic significance of immunoglobulin heavy chain (IgH) cytogenetic abnormalities in patients with newly diagnosed multiple myeloma (NDMM) and explore their association with other high\u2010risk cytogenetic features.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods<\/jats:title>\n We retrospectively analyzed 503 NDMM patients treated between February 1, 2016, and February 29, 2024. Cytogenetic abnormalities were identified by fluorescence in\u00a0situ hybridization.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The study uncovered a significant correlation between IgH cytogenetic abnormality and an increased prevalence of anemia (\n p<\/jats:italic>\n \u2009<\u20090.001), thrombocytopenia (\n p<\/jats:italic>\n \u2009=\u20090.005), and the presence of high\u2010risk cytogenetic aberrations, including +1q21 (\n p<\/jats:italic>\n \u2009<\u20090.001) and P53 deletion (\n p<\/jats:italic>\n \u2009=\u20090.001). Patients afflicted with IgH cytogenetic abnormality were found to have more advanced stages of the disease, as indicated by higher Disease Stage (\n p<\/jats:italic>\n \u2009<\u20090.001), International Staging System (\n p<\/jats:italic>\n \u2009=\u20090.018), Revised International Staging System (RISS) (\n p<\/jats:italic>\n \u2009<\u20090.001), and Second Revision of the International Staging System (\n p<\/jats:italic>\n \u2009<\u20090.001). This cytogenetic abnormality was also linked to a markedly diminished progression\u2010free survival (PFS) across RISS I\u2013II, yet autologous stem cell transplantation (ASCT) offered significant improvement for PFS (\n p<\/jats:italic>\n \u2009<\u20090.05). Notably, the specific t(14;16) and t(14; undefined) were significantly associated with shorter PFS (\n p<\/jats:italic>\n \u2009<\u20090.001) and shorter overall survival (OS) (\n p<\/jats:italic>\n \u2009<\u20090.05). Additionally, the confluence of IgH cytogenetic abnormality with other cytogenetic abnormalities, particularly +1q21, P53 deletion, RB\/D13S319 deletion, and elevated LDH level, was found to exacerbate the disease outcome.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n IgH cytogenetic abnormalities indicate aggressive disease and poorer survival in NDMM, especially when accompanied by other high\u2010risk markers. ASCT may mitigate these adverse outcomes, supporting its role in individualized treatment strategies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1002\/cam4.71152","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:22:13Z","timestamp":1756286533000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating the Prognostic Complexity of\n IgH<\/scp>\n Cytogenetic Abnormalities in Multiple Myeloma Among Diverse\n IgH<\/scp>\n Cytogenetic Abnormalities\u2013Involved High\u2010Risk Stratifications"],"prefix":"10.1002","volume":"14","author":[{"given":"Yanqiu","family":"Xiong","sequence":"first","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"},{"name":"Department of Hematology Clinical Medical College, Affiliated Hospital of Chengdu University, Chengdu University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5576-1788","authenticated-orcid":false,"given":"Wenjiao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-7550","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-1014","authenticated-orcid":false,"given":"Ting","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu Sichuan China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3257"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.122"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101168"},{"issue":"1","key":"e_1_2_10_5_1","first-page":"S3","article-title":"Current Approaches to Management of Newly Diagnosed Multiple Myeloma","volume":"97","author":"Goel U.","year":"2022","journal-title":"American Journal of Hematology"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0061"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001687512"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647636"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13440"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12882"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00348-5"},{"issue":"182","key":"e_1_2_10_14_1","article-title":"Interphase Fluorescence in Situ Hybridization of Bone Marrow Smears of Multiple Myeloma","author":"Yu Y.","year":"2022","journal-title":"Journal of Visualized Experiments"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.247"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00776"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004992"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0616"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00797-8"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00218-1"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30734-0"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00860"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18536"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02614"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2208914"},{"issue":"1","key":"e_1_2_10_26_1","first-page":"158","article-title":"Prognostic Value of R\u2010ISS Staging Combined With \u201cMultiple\u2010Hits\u201d in Patients With Multiple Myeloma","volume":"29","author":"Sun H. M.","year":"2021","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33208"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30323-9"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130092"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.934008"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.01.019"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102823"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.204"},{"issue":"1","key":"e_1_2_10_34_1","article-title":"EHA2024 Hybrid Congress","volume":"8","author":"Kastritis E.","year":"2024","journal-title":"Hemasphere"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17627"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00933-4"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25758"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.83"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1668-y"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.199"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.71152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:31:44Z","timestamp":1761129104000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.71152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":39,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1002\/cam4.71152"],"URL":"https:\/\/doi.org\/10.1002\/cam4.71152","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"type":"print","value":"2045-7634"},{"type":"electronic","value":"2045-7634"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"2025-05-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71152"}}